OTO-313 in Subjects With Subjective Tinnitus

NCT03918109 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinnitus, Subjective

Interventions

DRUG: OTO-313
DRUG: Placebo

Sponsor

Otonomy, Inc.